FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF-21 has been identified as a novel metabolic regulator based on findings that it protects animals from diet-induced obesity when overexpressed in transgenic mice and lowers blood glucose and triglyceride levels when administered to diabetic rodents13, 14.